With the publication of Drug Discovery in Leishmaniasis by Luis Rivas and Carmen Gil, the Drug Discovery Series sees the milestone publication of 60 books in the series.
Led by Editor in Chief David Thurston, the series covers all aspects of drug discovery and medicinal chemistry making use of expert case studies to accessibly detail both fundamental science and cutting-edge technologies. Since 2010 with the publication of Metabolism, Pharmacokinetics and Toxicity of Functional Groups the series has gone on to cover hot topics from nanomedicines and epigenetics to anti-aging drugs and green chemistry.
Books in the series include:
- Organic Chemistry of Drug Degradation edited by Min Li (ISBN 978-1-84973-421-9, 2012)
- New Frontiers in Chemical Biology: Enabling Drug Discovery edited by Mark Bunnage (ISBN 978-1-84973-125-6, 2010)
- Peptide-based Drug Discovery edited by Ved Srivastava (ISBN 978-1-78262-732-6, 2017)
View all 60 titles in the Drug Discovery Series.